A 2026 mouse study found that fucoidan from sea cucumber reduced artery plaque and blood fats after 12 weeks. According to research reviewed by Gram, the compound appears to cut fat absorption in the gut and help the liver clear cholesterol. Human effects remain unproven.
According to research reviewed by Gram, a study in Frontiers in Nutrition tested fucoidan, a sugar-based fiber from a sea cucumber species called Pearsonothuria graeffei. Scientists fed mice bred to develop high cholesterol a rich, fatty diet for 12 weeks while giving some of them the fucoidan by mouth each day. The treated mice had fewer fatty plaques in their main artery, less body-wide inflammation, and healthier blood fat levels. The fucoidan appeared to reduce fat absorption in the gut, help the liver clear cholesterol, and increase the production of bile acids, which help digest fat. Because the work was done in mice, it does not prove the same effects in people, but it points to a promising food ingredient worth testing in humans.
Key Statistics
A 2026 study in Frontiers in Nutrition found that mice given fucoidan from the sea cucumber Pearsonothuria graeffei at 20 or 80 mg per kg daily for 12 weeks had fewer fatty plaques in their aortas than untreated mice on the same high-fat diet.
A 2026 mouse study reported that fucoidan reduced the gut proteins CD36 and MTP, which help absorb dietary fat, while increasing liver proteins LDLR and ABCG5 that help clear cholesterol.
The Quick Take
- What they studied: Scientists wanted to know whether a fiber-like compound from sea cucumbers could protect against clogged arteries and high blood fats, and how it might work in the body.
- Who participated: The study used mice that were bred without a gene that normally clears fat from the blood, so they develop high cholesterol and artery plaque easily. The sample size was not reported in the study summary. These were animals, not people.
- Key finding: Mice given the fucoidan along with a high-fat diet for 12 weeks had fewer fatty plaques in their arteries, lower inflammation, and better blood fat levels than mice that did not receive it. The study reports results at two doses, 20 and 80 mg per kg of body weight.
- What it means for you: This is early animal research, so it cannot tell you what to eat or take. It does suggest that fucoidan could one day be useful as a functional food ingredient, but human studies are needed before any health claims can be made.
The Research Details
Researchers used mice that lack a gene called ApoE, which normally helps the body clear fats from the blood. Without it, these mice develop high cholesterol and fatty buildup in their arteries, making them a common model for heart disease research. All the mice ate a high-fat diet for 12 weeks, which is a standard way to push these animals toward artery problems.
Some mice also received fucoidan by mouth once a day at two different amounts, 20 and 80 mg per kg of body weight. Comparing these groups to mice that got no fucoidan allowed the team to see what the compound itself was doing, rather than relying on guesses about the diet alone.
To understand how the fucoidan worked, the scientists measured proteins and fats in the intestines, liver, feces, and artery walls. This helped them trace the likely steps, from less fat being absorbed in the gut to more cholesterol being cleared by the liver.
Testing in animals with a known path to artery disease lets scientists see both whether a compound works and how it works. This step comes before human trials, where safety and dose must be confirmed. Measuring the same processes across the gut, liver, and arteries also helps show that the effects are connected rather than coincidental.
The study was published in a peer-reviewed nutrition journal, and it tested more than one dose, which strengthens the case that the effect is linked to the compound. However, the summary does not report how many mice were used in each group, which makes it harder to judge how reliable the numbers are. Animal results also do not always carry over to people, so the findings should be viewed as early evidence.
What the Results Show
The main result was that mice receiving fucoidan had fewer fatty plaques in their aortas, the large artery leaving the heart. This is the type of buildup that can narrow blood vessels over time. The researchers also reported that inflammation throughout the body was reduced, and that blood fat levels were improved compared to mice that did not get the compound.
The team found that the fucoidan appeared to lower fat absorption in the small intestine. It did this by reducing the levels of two proteins, CD36 and MTP, which help the gut take in fat and move it into the bloodstream. Less fat getting into the blood means less material available to build up in artery walls.
At the same time, the liver seemed to get better at clearing cholesterol. The compound increased levels of LDLR and ABCG5, two proteins involved in removing cholesterol from the body. The liver also made more bile acids, which are substances that help digest fat, as a result of higher levels of the enzymes CYP7A1 and CYP27A1.
The researchers supported these ideas by finding more fat in the feces and more bile acids in the liver of treated mice. Together, these findings suggest that the compound helped the body remove fat before it could cause harm, rather than simply masking the problem.
The study also points to fucoidan as a possible food ingredient, not just a drug-like substance. Because it works through the digestive system, it could potentially be added to foods in the future. Its anti-inflammatory effects may also matter, since chronic inflammation is linked to artery disease. Still, these secondary ideas come from the same animal experiments and need human confirmation.
Earlier research has described fucoidan from various seaweeds and sea creatures as having anti-inflammatory and cholesterol-lowering properties. This study builds on that work by showing specific steps in the gut and liver that may explain those effects. It adds a clearer picture of the mechanism, although it is still one of many early studies in this area.
The most important limitation is that the study was done in mice, and mice do not process fats and cholesterol exactly like humans. The sample size was not clearly reported in the summary, so the strength of the results is hard to judge. The study also tested only one type of fucoidan from one sea cucumber species, so other versions may behave differently. Finally, the research does not show whether the same doses would be safe or effective in people, or how long the benefits would last.
The Bottom Line
Based on this single animal study, there is low confidence that fucoidan will help people with cholesterol or heart health. The results are promising enough to justify human research, but they do not support changing your diet or taking supplements right now. Standard, proven steps such as eating more fiber, limiting saturated fat, and staying active remain the best-supported choices.
People with high cholesterol, heart disease risk, or an interest in functional foods may find this research worth following. Researchers and food companies developing new ingredients will likely pay close attention. Anyone already taking cholesterol medication should not stop or change treatment based on this study, and people who are pregnant, nursing, or taking blood thinners should talk to a doctor before trying any new supplement.
If future human trials are successful, it could take several years of research before fucoidan-based foods or supplements become available. Even then, benefits to cholesterol and artery health usually build slowly over months, not days. For now, no timeline for personal benefit can be reliably set based on this mouse study.
Frequently Asked Questions
Can fucoidan from sea cucumbers lower cholesterol in people?
Not yet proven. A 2026 study showed cholesterol and artery benefits in mice fed a high-fat diet for 12 weeks. Human trials are needed to confirm whether fucoidan has the same effects in people, and at what dose it might be safe.
What is fucoidan and where does it come from?
Fucoidan is a sugar-based fiber found in certain seaweeds and sea creatures. In this study, researchers extracted it from the sea cucumber Pearsonothuria graeffei and tested it as a functional food ingredient to see how it affects fat absorption and cholesterol.
How does fucoidan appear to help protect arteries?
According to research reviewed by Gram, fucoidan appeared to reduce fat absorption in the mouse gut, boost cholesterol removal by the liver, and increase bile acid production. These steps together were linked to fewer fatty plaques in the aorta after 12 weeks.
Want to Apply This Research?
- Log your daily fiber intake in grams and track your fasting LDL cholesterol result from your doctor’s lab work every three to six months. Note any new fiber-rich foods you add, such as oats, beans, or seaweed, so you can see how they relate to your numbers over time.
- Add one soluble fiber food to a meal each day, such as oatmeal, lentils, or apples. These are proven to support healthy cholesterol levels and are a safer starting point than any experimental supplement. Use the app to set a weekly goal of eating fiber at three or more meals.
- Review your fiber intake, meals, and lab results together every quarter to spot patterns. Keep a note of any new research updates on fucoidan, and discuss them with your doctor before making changes. Long-term tracking should focus on your blood pressure, cholesterol, and overall diet quality.
This article summarizes an animal study in mice and is not medical advice. Results in mice do not guarantee the same effects in people. Please talk with a doctor or registered dietitian before starting any supplement or changing your diet to manage cholesterol or heart health.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.